Abstract
BackgroundGenes are regulated by various types of regulators and most of them are still unknown or unobserved. Current gene regulatory networks (GRNs) reverse engineering methods often neglect the unknown regulators and infer regulatory relationships in a local and sub-optimal manner.ResultsThis paper proposes a global GRNs inference framework based on dictionary learning, named dlGRN. The method intends to learn atomic regulators (ARs) from gene expression data using a modified dictionary learning (DL) algorithm, which reflects the whole gene regulatory system, and predicts the regulation between a known regulator and a target gene in a global regression way. The modified DL algorithm fits the scale-free property of biological network, rendering dlGRN intrinsically discern direct and indirect regulations.ConclusionsExtensive experimental results on simulation and real-world data demonstrate the effectiveness and efficiency of dlGRN in reverse engineering GRNs. A novel predicted transcription regulation between a TF TFAP2C and an oncogene EGFR was experimentally verified in lung cancer cells. Furthermore, the real application reveals the prevalence of DNA methylation regulation in gene regulatory system. dlGRN can be a standalone tool for GRN inference for its globalization and robustness.
Highlights
Genes are regulated by various types of regulators and most of them are still unknown or unobserved
It has been acknowledged that aberrant gene networks can be a key driver of human diseases including cancer, little is known about the gene regulatory networks (GRNs) of cancer, which has largely impeded the development of cancer precision medicine [3,4,5]
Speaking, according to the way of modeling transcriptional expression patterns [8], current GRN inference methods can be divided into two categories: parameterized topology paradigm (PTP) and un-parameterized
Summary
Genes are regulated by various types of regulators and most of them are still unknown or unobserved. It has been acknowledged that aberrant gene networks can be a key driver of human diseases including cancer, little is known about the GRNs of cancer, which has largely impeded the development of cancer precision medicine [3,4,5]. In these years, a deluge of omics big data has been generated and accumulated. Refer to other literature, e.g. [6, 14, 16,17,18]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.